- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05917002
MPFC Theta Burst Stimulation as a Tool to Affect Rational Decision Making
September 2, 2025 updated by: Medical University of South Carolina
This is a study to investigate if a device that temporarily changes brain activity (repetitive transcranial magnetic stimulation, rTMS) might be used to change how healthy participants make decisions.
This study involves 2 visits to MUSC that will each take between 2-3 hours.
This study is not a treatment study, but it could help inform studies investigating treatment in the future.
Participants in this study will be compensated for their time.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Detailed Description
This study aims to investigate whether a single session of excitatory repetitive transcranial magnetic stimulation (rTMS) compared to electrical sham stimulation to the medial prefrontal cortex (mPFC) facilitates rational decision making.
Our prior data suggests that decisions are biased depending on if the available options are presented with a negative or positive connotation (even in the case of mathematical equivalence).
Work by us and others has demonstrated that even if both options are equal, the negatively framed choice is most often avoided.
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Is able to read consent document and provide informed consent
- English is first or primary language
Exclusion Criteria:
• Current psychiatric disorder (as defined by DSM-5 and determined using standardized self-report instruments)
- Suicide attempt in the past year
- Lifetime diagnosis of psychotic disorder or bipolar mania
- Presence of neurological disorder that contraindicates TMS or neurophysiological recording:
- Seizure disorder
- Lifetime history of traumatic brain injury with loss of consciousness
- Neurodegenerative disorder (e.g., Alzheimer's Disease, Parkinson's Disease, Frontotemporal Dementia)
- Presence of standard contraindications for rTMS
- Currently pregnant
- Significant sensitivity to noise
- Medical treatments or conditions that lower seizure threshold
- History of severe brain injury
- History of seizures/epilepsy
- Currently taking chronic opiate medications or substances
- Inability or unwillingness of subject to give informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Real TBS to the mPFC
The type of stimulation to be used will be intermittent theta burst (iTBS) stimulation to the mPFC with a figure 8 coil (Coil Cool-B65 A/P).
Participants will receive three 3-minute sessions of iTBS (600 pulses; 190s; 120% resting motor threshold) with 10-15-minute breaks in between each session or more per participant preference.
|
This will be delivered with the Magventure MagPro System; (double blinded using the integrated active sham system).
|
|
Sham Comparator: Sham TBS to the mPFC
The MagVenture MagPro system has an integrated, active sham which passes current through two surface electrodes placed on the scalp.
The electrodes will be placed on the left frontalis muscle for all sessions.
A patient identification card will randomize participants to receive either sham or active stimulation in the first session.This system maintains blinding by a gyroscope in the coil which indicates to the clinical staff whether the coil should be rotated up or down for this participant once the card is entered into the machine.
One side of the coil is active, the other is sham.
The integrity of the double blind procedure will be assessed by asking the patients and study personnel rate their confidence regarding whether they thought they received real or sham.
(Scale 1-10)
|
This will be delivered with the Magventure MagPro System; (double blinded using the integrated active sham system).
The Magventure MagPro system has an integrated active sham that passes current through two surface electrodes placed on the scalp.
The electrodes are placed on the left frontalis muscle under the coil for both the real and sham stimulation sessions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Baratt Impulsiveness Scale
Time Frame: Change assessed at visit 1 (day 1) and visit 2 (day 2)
|
Change in 30-item self-report scale that is commonly used to measure impulsiveness.
Participants respond to each item using a 4-point Likert scale: 1 (rarely/never), 2 (occasionally), 3 (often), and 4 (almost always/always).
|
Change assessed at visit 1 (day 1) and visit 2 (day 2)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Lisa McTeague, Ph.D., Medical University of South Carolina
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2025
Primary Completion (Actual)
August 1, 2025
Study Completion (Actual)
August 1, 2025
Study Registration Dates
First Submitted
March 29, 2023
First Submitted That Met QC Criteria
June 20, 2023
First Posted (Actual)
June 23, 2023
Study Record Updates
Last Update Posted (Estimated)
September 8, 2025
Last Update Submitted That Met QC Criteria
September 2, 2025
Last Verified
September 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- Pro00126644
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
University of Vermont Medical CenterAvocado Nutrition CenterRecruitingHealthy | Healthy Volunteers | Healthy Subjects | Healthy Volunteer | Healthy Adult | Healthy Volunteers Only | Healthy Male and Female Subjects | Healthy Non-smokersUnited States
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
University of PalermoCompletedHealthy | Healthy Volunteers | Healthy Subjects | Healthy Participants | Static Stretching | Stretch | StretchingItaly
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
PfizerNot yet recruitingHealthy | Healthy AdultsUnited States
-
Atisama TherapeuticsRecruitingHealthy | Healthy SmokerAustralia
Clinical Trials on Real TBS to mPFC
-
Wake Forest University Health SciencesCompletedBack Pain | Chronic Pain | Neuropathic Pain | Opioid Use | Pain, Chronic | Opiate Dependence | Chemotherapy-induced Peripheral Neuropathy | Chronic Lower Back PainUnited States
-
Medical University of South CarolinaNational Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institutes...RecruitingAlcohol Drinking | Substance Use | Alcohol Use Disorder | Drinking, Alcohol | Alcohol Use Disorder (AUD)United States
-
Shanghai Mental Health CenterCompletedAmphetamine Use DisordersChina
-
Wake Forest University Health SciencesTerminatedHealthy | Chronic Pain | Opioid Use | Pain, ChronicUnited States
-
Wake Forest University Health SciencesNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcohol Dependence | Alcohol Use Disorder | Craving | Alcohol AbuseUnited States
-
Wake Forest University Health SciencesVirginia Tech Carilion School of Medicine and Research InstituteCompletedSmoking | Smoking Cessation | Addiction | Nicotine Dependence | Craving | Addiction Nicotine | Cigarette SmokingUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)CompletedLower Back Pain | Chronic Pain | Opiate DependenceUnited States
-
Institut National de la Santé Et de la Recherche...CompletedFrontotemporal Dementia | Behavior | Apathy
-
Public Health Management CorporationDepartment of Health and Human ServicesCompletedPregnancy in AdolescenceUnited States
-
University of TorontoRecruitingSchizophrenia Spectrum & Other Psychotic DisordersCanada